1. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
   Yan-Le Xin et al, 2015, Bioscience Reports CrossRef
2. Characterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male rats
   P.E. Juif et al, 2015, Neuropharmacology CrossRef
3. Differentiation of human amniotic epithelial cells into Schwann-like cells via indirect co-culture with Schwann cells in vitro
   SHUANG ZHU et al, 2015, Molecular Medicine Reports CrossRef
4. Anxiolytics targeting GABAA receptors: Insights on etifoxine
   Pierrick Poisbeau et al, 2018, The World Journal of Biological Psychiatry CrossRef
5. Etifoxine for Pain Patients with Anxiety
   Yun Mi Choi et al, 2015, The Korean Journal of Pain CrossRef
6. China’s landscape in regenerative medicine
   Xin Tang et al, 2017, Biomaterials CrossRef
7. Ginkgo Biloba Extract (EGb 761) Promotes Peripheral Nerve Regeneration and Neovascularization After Acellular Nerve Allografts in a Rat Model
   Zhaowei Zhu et al, 2015, Cellular and Molecular Neurobiology CrossRef
8. Physiological and Cellular Targets of Neurotrophic Anxiolytic Phytochemicals in Food and Dietary Supplements
   Benjamin S. Weeks et al, 2021, Functional Foods - Phytochemicals and Health Promoting Potential CrossRef
9. Tacrolimus-Induced Neurotrophic Differentiation of Adipose-Derived Stem Cells as Novel Therapeutic Method for Peripheral Nerve Injury
   Xiangyun Yao et al, 2021, Frontiers in Cellular Neuroscience CrossRef
10. A genetic pedigree analysis to identify gene mutations involved in femoral head necrosis
    LIN WANG et al, 2014, Molecular Medicine Reports CrossRef
11. Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine
    Mona Shehadeh et al, 2019, International Journal of Molecular Sciences CrossRef